This leader will be an embedded, working member of the cross-functional program team—alongside Clinical Development, Clinical Operations, Regulatory Affairs, Medical Affairs, Translational Medicine and Program Management—authoring and owning statistical analysis plans, defining estimands, performing analyses and driving the statistical content of protocols, health-authority interactions and scientific presentations. Reporting to the VP, Program Management and Head of Clinical Trial Services, the Senior Director / Executive Director, Biostatistics will lead the biostatistics strategy for the NKX019 autoimmune program—from ongoing multi-indication Phase 1/2 studies through potential pivotal trial design—and will be Nkarta's most senior statistical voice with the FDA, the Board, investigators, partners and the scientific community.